11. Development Stage Supplemental Equity Disclosure
Summarized below are the Company’s equity (common stock and common stock options) transactions since the Company’s inception through December 31, 2013.
Type of Security |
Date of Issuance |
Shares of Common Stock |
Dollar Amount of Consideration ($) |
Price per Share or Exercise Price per Share ($) |
Counter Party to Transaction |
Nature of Non-Cash Consideration |
Basis of Assigning Cost |
|||||||||||||
Common Stock |
September 8, 2011 | 100 | — | 0.01 | Galena | NA | Cash | |||||||||||||
Common Stock |
April 27, 2012 | 3,347,996 | NA | 0.27 | Galena | NA | Independent Third Party Valuation | |||||||||||||
Common Stock |
April 27, 2012 | 1,394,997 | NA | 4.43 | Advirna | Intellectual Properties | Market Value | |||||||||||||
Common Stock |
Various - 2012 | 546,014 | NA | 0.41 |
Conversion of Series A Preferred Stock |
NA | Cost Basis | |||||||||||||
Common Stock |
March 12, 2013 | 3,765,230 | 15,651 | 4.35 | PIPE | NA | Net Cash | |||||||||||||
Common Stock |
March 12, 2013 | 1,666,666 | NA | 4.35 | Opko | Intellectual Properties | Market Value | |||||||||||||
Common Stock |
Various - 2013 | 1,056,684 | NA | 0.41 |
Conversion of Series A Preferred Stock |
NA | Cost Basis | |||||||||||||
Common Stock |
September 11, 2013 | 2,000 | 5 | 2.55 |
Exercise of Stock Options |
NA | Cash | |||||||||||||
Common Stock |
December 31, 2013 | 11,265 | 28 | 2.61 | ESPP | NA | Cash |